Dr. Scott Tebbutt is Chief Executive Office (since 2020) and Chief Scientific Officer (since 2009), of the Prevention of Organ Failure (PROOF) Centre of Excellence.
Dr. Tebbutt provides leadership, general supervision, management and control of the operations of the Centre on a day-to-day basis in accordance with the plans and policies approved by the Board. He provides overall leadership and vision in developing the strategy, tactics and plans necessary to realize the Centre’s objectives, and he manages the Centre to ensure annual plans are effectively implemented, with the results monitored and reported to the Board, and financial and operational objectives attained.
His scientific responsibilities have included the evaluation and deployment of new, high-performance technologies to improve biomarker discovery, development and implementation, as well as bioinformatic approaches to better deal with sample heterogeneity and integration of high-dimensional omic datasets. He leads major biomarker programs in lung disease, heart transplantation, vaccine immunogenicity, and COVID-19, and he directly supervises many of the PROOF Centre’s trainees.
Dr. Tebbutt is also Professor in the Department of Medicine (Respiratory Division), University of British Columbia, as well as Principal Investigator and Director of Education at the Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, Canada. His academic research program is focused on the molecular and cellular understanding of complex disease and other health-related conditions, including inflammatory disorders of the lung, allergic rhinitis, heart failure, and neonatal vaccinology.
Dr. Tebbutt has served on numerous local and international scientific advisory committees, including the BC Children’s Hospital Research Institute “Transplantation and Cell Therapy (TRACE) Program Biomarker and Cell Therapy Oversight Committee (BCTOC),” the United States National Institutes of Health Human Immunology Project Consortium (HIPC) “Biostatistics and Bioinformatics Subcommittee,” and the Coalition for Epidemic Preparedness Innovations (CEPI) “Systems Immunology Task Force.” He is a member of the Human Vaccines Project (HVP) Bioinformatics Hub, a member of the Langara College Program Advisory Committee (PAC) for the Bachelor of Science in Bioinformatics program (Vancouver, Canada), and a member of Providence Health Care’s Joint Steering Committee for Multi-omics & Medical Imaging Datalab – MOMI (Vancouver, Canada).
He holds a B.A. in biochemistry from the University of Oxford and a Ph.D. in molecular genetics from the University of East Anglia (Cambridge Laboratory, John Innes Centre).
